Apolipoprotein A-I (ApoA-I) agonists and their use to treat dyslipidemic disorders and prevent toxic shock

摘要

Peptides and peptide analogues that mimic the structural and pharmacological properties of human ApoA-I are described. The peptides and peptide analogues are useful to treat a variety of disorders associated with dyslipidemia and toxic shock.